Academic Journal
Q1Ageing Research Reviews
About Ageing Research Reviews
Ageing Research Reviews is a scholarly journal published by Elsevier Ireland Ltd. SCImago 2025 places it in Q1 with an SJR of 4.289 and an H-index of 194.
Its listed coverage is 2002-2026 and its research categories include Aging (Q1); Biochemistry (Q1); Biotechnology (Q1); Molecular Biology (Q1); Neurology (Q1). The 2025 dataset reports 234 documents and 14832 citations across the latest three-year reporting window.
Ageing Research Reviews is one of the most reputable and influential journals in the field of gerontology and ageing science. Published by Elsevier, this peer-reviewed journal offers comprehensive reviews and analyses of the latest advancements in ageing research, making it an essential resource for scientists, clinicians, and policy makers around the world. With the increasing global interest in healthy aging and anti-ageing interventions, the journal plays a crucial role in shaping the future of longevity science.
What is Ageing Research Reviews?
Ageing Research Reviews (ARR) is an international review journal that publishes high-quality, scholarly articles focused on the biological, biochemical, and genetic mechanisms of ageing. It covers a wide spectrum of topics, including cellular senescence, DNA damage, neurodegeneration, age-related diseases, and cutting-edge anti-ageing therapies.
This journal is highly cited in academic circles and ranks among the top ageing journals globally. Its impact factor reflects its role in guiding both academic research and practical approaches toward improving lifespan and healthspan.
Why is Ageing Research So Important?
As the global population continues to age, the demand for solutions that promote longer, healthier lives has never been greater. Ageing research seeks to understand why we age and how we can delay or even reverse some of the effects of ageing. This includes studying molecular biology, genetics, lifestyle factors, and pharmacological interventions.
The ultimate goal of this field is not just lifespan extension, but also the improvement of quality of life in old age—reducing the burden of age-related diseases like Alzheimer's, cancer, and cardiovascular disorders.
Topics Covered in Ageing Research Reviews
ARR offers in-depth reviews across a broad range of scientific disciplines. Key topics often featured include:
-
Molecular and cellular mechanisms of ageing
-
Genetic regulation of lifespan
-
Caloric restriction and its effects on aging
-
Mitochondrial dysfunction in elderly populations
-
Emerging anti-ageing drugs and therapeutics
-
Inflammation and immunosenescence
-
Brain aging and neurodegeneration
By synthesizing findings from multiple studies, the journal helps researchers identify patterns, gaps in knowledge, and promising new directions in geroscience.
Who Should Read This Journal?
Whether you're a biomedical researcher, gerontologist, clinician, or student, Ageing Research Reviews offers valuable insights. It’s also increasingly popular among biotech companies and pharmaceutical firms developing anti-ageing treatments and age-related disease prevention strategies.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Ageing Research Reviews is a leading scientific journal that publishes high-quality, peer-reviewed review articles focusing on the biological, molecular, clinical, and social aspects of aging. As the global population continues to age rapidly, research in this field is gaining significant momentum. The scope of Ageing Research Reviews (ARR) reflects the growing interest in understanding the complex mechanisms of aging and the development of strategies to promote healthy longevity.
Interdisciplinary Approach to Aging
The journal adopts an interdisciplinary approach, integrating findings from biology, medicine, neuroscience, genetics, psychology, and public health. This wide-ranging perspective allows researchers and clinicians to explore age-related changes across different biological systems and how these changes affect physical and cognitive health. By providing a platform for comprehensive reviews, Ageing Research Reviews encourages knowledge exchange among professionals in diverse scientific domains.
Focus Areas of the Journal
The scope of the journal includes, but is not limited to:
-
Molecular and Cellular Mechanisms of Aging: Exploring pathways like telomere shortening, mitochondrial dysfunction, oxidative stress, and cellular senescence.
-
Neurodegenerative Diseases: Reviews on Alzheimer’s disease, Parkinson’s disease, and other age-related cognitive impairments.
-
Longevity and Lifespan Extension: Research on caloric restriction, pharmacological interventions (e.g., rapamycin, metformin), and gene therapy.
-
Age-related Disorders: Articles discussing osteoporosis, cardiovascular diseases, diabetes, and immune system aging.
-
Social and Psychological Aspects: Cognitive decline, mental health, social isolation, and their impact on aging populations.
Promoting Translational Research
One of the key goals of Ageing Research Reviews is to bridge the gap between basic science and clinical application. By focusing on translational ageing research, the journal helps accelerate the development of new treatments, preventive strategies, and public health policies aimed at improving the quality of life for older adults.
Target Audience
This journal serves as a valuable resource for:
-
Gerontologists
-
Biogerontologists
-
Biomedical researchers
-
Clinicians
-
Public health experts
-
Policy makers in aging and healthcare
With its high impact factor and rigorous peer-review process, Ageing Research Reviews attracts top-tier authors and provides authoritative content that informs future research directions.
Contribution to Global Aging Challenges
As the world’s elderly population grows, countries face numerous challenges in managing healthcare, pensions, and elderly care services. Journals like Ageing Research Reviews play a crucial role in shaping global strategies for healthy aging, promoting independent living, and reducing age-related health burdens.
Recent Research Articles
Latest publications matched automatically by ISSN.
Tryptophan metabolism regulates immunosenescence and inflammaging: The macrophage immunometabolic axis and therapeutic targets
Dengchuan Wang, Shi Xu, Yonggang Zhang
2026-11 · DOI: 10.1016/j.arr.2026.103307The force-producing fraction: Muscle quality as a therapeutic target in sarcopenia and a design framework for trials that can test it
Ju Hun Oh, Cheol Ryong Ku, Chang-Myung Oh
2026-11 · DOI: 10.1016/j.arr.2026.103349Neuro-metabolic ageing drives diabetes-associated neurodegeneration: A geroscience and network pharmacology perspective
Sakshi Tiwari, Bilal Siddiqui, Saman Fatima, Monica Saifi et al.
2026-11 · DOI: 10.1016/j.arr.2026.103308Vaccination strategies in neurodegenerative proteinopathies
Chunhao Tao, Deming Zhao, Lifeng Yang
2026-11 · DOI: 10.1016/j.arr.2026.103337Ageing of the skeletal muscle as a barrier to cell therapy: Cell sources, microenvironmental failure and autologous alternatives
Inseon Kim, Yejin Song, Seohyun Choo, Seunghun S. Lee et al.
2026-11 · DOI: 10.1016/j.arr.2026.103320Chemokines in cardiovascular and cerebrovascular pathogenesis: Emerging therapeutic targets
Jiaxing Wang, Yunfeng Ni, Hui Chang, Mingzhen Zhang et al.
2026-11 · DOI: 10.1016/j.arr.2026.103295Targeting the mitochondrial functional network: Decoding upstream pathological mechanisms and novel therapeutic paradigms for Alzheimer’s disease
Xiong Li, Rui Wan, Yumeng Wu, Yang Zhao et al.
2026-11 · DOI: 10.1016/j.arr.2026.103359Ambient air pollution exposure and cognitive aging, mediators and possible pathways: A systematic review on the epidemiological studies
Mohammad Javad Zare Sakhvidi, Emilie Burte, AmirHoushang Mehrparvar, Marion Mortamais et al.
2026-11 · DOI: 10.1016/j.arr.2026.103330Anti-amyloid drugs: Integrated clinical pathways for treating older patients with frailty and dementia
Vincenzo Solfrizzi, Madia Lozupone, Francesco Panza
2026-11 · DOI: 10.1016/j.arr.2026.103331Senescent repair memory in chronic disease: Failed resolution as a driver of persistent organ dysfunction
Hongtu Hu, Rui Ji, Jijia Hu
2026-11 · DOI: 10.1016/j.arr.2026.103321Precision medicine breakthrough: Multi-omics integration elevates CAD risk prediction
Qiang Su, Qiu-Yan Li, Chen-Kai Hu, Yuan Huang et al.
2026-11 · DOI: 10.1016/j.arr.2026.103306Aging's competing paradigms: Another decade of investigation into damage-driven versus programmed theories
Peter V Lidsky, Mikolaj Ogrodnik
2026-11 · DOI: 10.1016/j.arr.2026.103304Mechanisms and therapeutic strategies for VEGFR inhibitor-induced cardiotoxicity and hepatotoxicity in cancer therapy
Yajie Peng, Xinyi Chao, Qiubin Song, Zining Li et al.
2026-11 · DOI: 10.1016/j.arr.2026.103336The silent infection load: How lifelong asymptomatic infections may contribute to inflammaging as an evolutionary trade-off of longevity
Andrea Cossarizza, Guido Poli, Mario Clerici
2026-11 · DOI: 10.1016/j.arr.2026.103340Valine metabolism in cardiovascular disease: Mechanistic insights and translational perspectives
Yi Luan, Ying Luan, Xing Chen, Kaidi Ren et al.
2026-11 · DOI: 10.1016/j.arr.2026.103313Developmental programming of skeletal muscle aging by parental exercise: Intergenerational mechanisms and implications for lifelong muscle health
Zijian Li, Jie Li, Xiaoying Zhu, Guanfeng Qin et al.
2026-11 · DOI: 10.1016/j.arr.2026.103316E3 Ubiquitin ligases molecular strategies against proteostasis defects of imperfect ageing
Arun Upadhyay, Vibhuti Joshi, Ayeman Amanullah, Ribhav Mishra et al.
2026-11 · DOI: 10.1016/j.arr.2026.103319Somatic mutations in human ontogenesis and their impact on health
Oleg Sergeyev, Vasily Ashapkin, Dmitry Korostin, Vitalik Bezuglov et al.
2026-11 · DOI: 10.1016/j.arr.2026.103338The senescence–immune axis as a target for combining immunotherapy and senotherapy
Fernanda Saez-Calazans, Lucas Kich Grun, Lucas Emanuel Stein, Florencia Barbé-Tuana et al.
2026-11 · DOI: 10.1016/j.arr.2026.103309Living beyond our evolutionary warranty: Why non-communicable diseases may be the inevitable costs of an extended lifespan
Archibold Mposhi, Kerstin Uvnas-Moberg, Jonathan D. Turner
2026-11 · DOI: 10.1016/j.arr.2026.103343Reviews
Community Reviews
Version History
April 22, 2025 at 11:42 am
April 22, 2025